Peptide data sheet
Hexarelin
Performance · Examorelin
Verdict
unprovenno human outcome data
Quick answer
Hexarelin is a synthetic six-amino-acid growth-hormone-releasing peptide, commonly researched for its strong effect on GH release and for a separate cardiac-tissue signal in animal models. Human outcome data is thin, so the verdict stays Unproven. It is not FDA-approved and is prohibited in sport under the WADA growth-hormone-secretagogue category.
- Class
- Growth-hormone-releasing peptide (GHRP-6 analog)
- Half-life
- Short (reported in the range of tens of minutes in early human studies)
- FDA status
- Not FDA-approved (sold as a research chemical)
- WADA banned?
- Yes
Which form actually works?
Injectable (subcutaneous research vial)
Unproven
The form used in most published animal and early human research. Studied for GH release, but long-term human outcome data is absent and gray-market sourcing adds contamination risk.
Intranasal
Unproven
An intranasal route appeared in some early pharmacology work, but human outcome evidence for it is minimal and it is not an established delivery form.